FENC · Fennec Pharmaceuticals Inc.

Represents shares sold pursuant to a 10b5-1 plan dated September 19, 2025.

Represents shares released from restriction from shares awarded 3/28/2025.

Represents shares released from restriction from shares awarded 5/16/2024 and 3/28/2025.

Represents shares released from restriction from shares awarded 5/16/2024.

Represents shares released from restriction from shares awarded 3/28/2025.

Represents shares released from restriction from shares awarded 3/28/2025.

Represents shares released from restriction from shares awarded 3/28/2025.

Represents options exercised pursuant to a 10b5-1 plan adopted on September 19, 2025.

Shares acquired through the exercise of an option pursuant to a 10b5-1 plan adopted on September 19, 2025.

Represents shares released from restriction from shares awarded 5/16/2024.

Shares sold to satisfy tax obligation on option exercise pursuant to a 10b5-1 plan adopted on September 19, 2025.

Represents shares released from restriction from shares awarded 3/28/2025.

Represents shares released from restriction from shares awarded 5/16/2024 and 3/28/2025.

Represents shares released from restriction from shares awarded 3/28/2025.

Represents shares released from restriction from shares awarded 3/28/2025.

Represents shares released from restriction from shares awarded 3/28/2025.

On June 10, 2026, Khalid Islam was granted a non-qualified stock option to purchase 25,000 shares of the issuer's common shares pursuant to the issuer's Equity Incentive Plan.

The option is 100% vested on date of grant.

On June 10, 2026, Marco Brughera was granted a non-qualified stock option to purchase 20,000 shares of the issuer's common shares pursuant to the issuer's Equity Incentive Plan.

The option is 100% vested on date of grant.

On June 10, 2026, Chris Rallis was granted a non-qualified stock option to purchase 20,000 shares of the issuer's common shares pursuant to the issuer's Equity Incentive Plan.

The option is 100% vested on date of grant.

On June 10, 2026, Jodi Cook was granted a non-qualified stock option to purchase 20,000 shares of the issuer's common shares pursuant to the issuer's Equity Incentive Plan.

The option is 100% vested on date of grant.

Shares sold to satisfy tax obligation on option exercise pursuant to a 10b5-1 plan adopted on September 19, 2025.

Represents options exercised pursuant to a 10b5-1 plan adopted on September 19, 2025.

Shares acquired through the exercise of an option pursuant to a 10b5-1 plan adopted on September 19, 2025.

Represents shares released from restriction from shares awarded 3/28/2025.

Represents shares released from restriction from shares awarded 5/16/2024.

Represents shares released from restriction from shares awarded 3/28/2025.

Represents shares released from restriction from shares awarded 5/16/2024 and 3/28/2025.

Represents shares released from restriction from shares awarded 3/28/2025.

Represents shares released from restriction from shares awarded 3/28/2025.

Shares sold to satisfy tax obligation on option exercise.

Represents options exercised pursuant to a 10b5-1 plan adopted on May 19, 2025.

Shares acquired through the exercise of an option pursuant to a 10b5-1 plan adopted on May 19, 2025.

Represents options exercised pursuant to a 10b5-1 plan adopted on September 19, 2025.

Shares acquired through the exercise of an option pursuant to a 10b5-1 plan adopted on September 19, 2025.

Shares sold to satisfy tax obligation on option exercise pursuant to a 10b5-1 plan adopted on September 19, 2025.

Represents shares released from restriction from shares awarded 3/28/2025.

Represents shares released from restriction from shares awarded 5/16/2024.

Represents shares released from restriction from shares awarded 3/28/2025.

Represents shares released from restriction from shares awarded 3/28/2025.

Represents shares released from restriction from shares awarded 3/28/2025.

Represents shares released from restriction from shares awarded 5/16/2024 and 3/28/2025.

Shares acquired through the exercise of an option pursuant to a 10b5-1 plan adopted on September 19, 2025.

Represents options exercised pursuant to a 10b5-1 plan adopted on September 19, 2025.

Shares sold to satisfy tax obligation on option exercise pursuant to a 10b5-1 plan adopted on September 19, 2025..

Represents settlement of PSUs that vested on March 31, 2026.

Represents shares released from restriction from shares awarded 3/28/2025.

On March 31, 2026, granted incentive stock options to purchase 120,000 shares of the issuers common shares pursuant to the Issuer's 2020 Equity Incentive Plan.

One-third of the shares subject to this option may be exercised as of March 31, 2027 ("Vesting Commencement Date"). One twenty-fourth of the shares subject to this option shall vest and may be exercised as of the last day of each month following the Vesting Commencement Date. As of March 31, 2029, 100% of the total number of shares subject to this option shall be vested.

Represents settlement of PSUs that vested on March 31, 2026.

On March 31, 2026, granted incentive stock options to purchase 120,000 shares of the issuers common shares pursuant to the Issuer's 2020 Equity Incentive Plan.

One-third of the shares subject to this option may be exercised as of March 31, 2027 ("Vesting Commencement Date"). One twenty-fourth of the shares subject to this option shall vest and may be exercised as of the last day of each month following the Vesting Commencement Date. As of March 31, 2029, 100% of the total number of shares subject to this option shall be vested.

Represents shares released from restriction from shares awarded 3/28/2025.